Finecare ImmunoAssay Analyzer (FS-205 Meter) – High-Throughput, Automated & Precision Diagnostic System

The Finecare FS-205 ImmunoAssay Analyzer is a next-generation fluorescence immunoassay platform designed to support medium-to-high workload laboratories with exceptional accuracy, automation, and speed. Engineered for advanced diagnostic performance, the FS-205 delivers reliable quantitative results across a broad menu of biomarkers—making it a powerful solution for hospitals, reference labs, and comprehensive diagnostic centers.

Key Features

• High Sensitivity Fluorescence ImmunoAssay Technology

  Ensures precise, laboratory-grade quantitative results with superior specificity.

• High Throughput & Multi-Channel Testing

  Capable of processing multiple samples simultaneously, improving turnaround time and workflow efficiency.

• Extensive Test Menu Compatibility

  Supports Finecare assay cartridges for:

  • Cardiac markers (TnI, CK-MB, Myoglobin)

  • Inflammation markers (CRP, PCT)

  • Thyroid function tests

  • Fertility & reproductive hormones

  • Diabetes markers (HbA1c, Insulin, C-peptide)

  • Tumor markers

  • Infectious disease markers

• Automated Testing Workflow

  Barcode scanning, automatic calibration, and simplified loading reduce manual handling.

• Large Touchscreen Display

  Intuitive interface designed for easy operation and quick navigation.

• Connectivity & Data Integration

  Supports LIS/HIS systems, USB transfer, internal storage, and external printing.

• Compact but High Capacity

  Ideal for laboratories requiring efficiency without compromising space.

Applications

• Medium to large hospital laboratories

• Diagnostic centers & reference labs

• Emergency departments

• Speciality clinics & endocrine labs

• Pharmacy diagnostic hubs

• Research & academic institutions

Why Choose the FS-205 Meter?

The Finecare FS-205 combines advanced automation, high throughput, and a broad diagnostic test range—making it a dependable choice for facilities that require fast, accurate, and scalable immunoassay testing.